FARAPULSE Revenue and Competitors
Estimated Revenue & Valuation
- FARAPULSE's estimated annual revenue is currently $6M per year.
- FARAPULSE's estimated revenue per employee is $251,000
Employee Data
- FARAPULSE has 24 Employees.
- FARAPULSE grew their employee count by -29% last year.
FARAPULSE's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Sr. Director Clinical and Preclinical Engineering | Reveal Email/Phone |
2 | Sr. Director, Quality Assurance | Reveal Email/Phone |
3 | Project Manager, Business Operations | Reveal Email/Phone |
4 | Principal Quality Engineer | Reveal Email/Phone |
5 | Field Service Engineer | Reveal Email/Phone |
6 | Principal Quality Engineer | Reveal Email/Phone |
7 | Sr. Clinical Research Associate | Reveal Email/Phone |
8 | Research And Development Engineer | Reveal Email/Phone |
9 | Senior Field Service Engineer | Reveal Email/Phone |
10 | Specialist II Regulatory Doc. Control | Reveal Email/Phone |
FARAPULSE Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $20.3M | 81 | 7% | N/A | N/A |
#2 | $8.5M | 34 | 6% | N/A | N/A |
#3 | $4.5M | 18 | -10% | N/A | N/A |
#4 | $8M | 32 | -6% | N/A | N/A |
#5 | $5.3M | 21 | 0% | N/A | N/A |
#6 | $54.2M | 216 | 9% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $10M | 40 | 5% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 56 | 2% | N/A | N/A |
What Is FARAPULSE?
FARAPULSE, Inc. is a medical devices company based out of 3715 Haven Avenue 110, Menlo Park, CA, United States.
keywords:N/A
N/A
Total Funding
24
Number of Employees
$6M
Revenue (est)
-29%
Employee Growth %
N/A
Valuation
N/A
Accelerator
FARAPULSE News
... from the acquisitions of Preventice, Farapulse, and Lumenis, and $13 million of pre-divestiture specialty pharmaceutical sales in 2021.
The pentaspline PFA catheter (Farapulse PFA System, Boston Scientific) is an over-the-wire catheter with variable distal basket and flower...
Boston Scientific in July 2021 exercised its option to acquire the remaining shares of PFA tech developer Farapulse.
Pioneering technology has demonstrated potential to improve safety for patients with paroxysmal atrial fibrillation and simplify procedures for physicians MENLO PARK, Calif., March 3, 2021 /PRNewswire/ - FARAPULSE Inc. today announced the first patients were treated in the ADVENT Trial, a U.S ...
Other Companies in Menlo Park
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.5M | 24 | 0% | N/A |
#2 | $2.4M | 24 | 26% | N/A |
#3 | $3.4M | 24 | 9% | N/A |
#4 | $2.4M | 24 | N/A | N/A |
#5 | $2.4M | 24 | 0% | N/A |